Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX vs Docetaxel, Oxaliplatin and S1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
NCT02623153Phase 2Unknown
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tegafur + gimeracil + oteracil, docetaxel in gastric cancer (GC). Status: unknown.
02
Drugs
tegafur + gimeracil + oteracildocetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02623153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623153.